Mutations in the transforming growth factor beta co-receptor, endoglin (ENG), account for approximately half of known HHT cases and cause abnormal angiogenic activity in endothelial cells (ECs). This evidence concerns the gene ENG and hereditary hemorrhagic telangiectasia.